All News about Alkermes Plc
![](https://investorplace.com/wp-content/uploads/2022/04/pte_biotech_1600-1024x576.png)
![](https://www.investors.com/wp-content/uploads/2017/05/IRU6.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/earnings_image.jpeg?width=1200&height=800&fit=crop)
![](/next-assets/images/schema-image-default.png)
Alkermes's Earnings Outlook
February 14, 2024
Via Benzinga
![](https://www.investors.com/wp-content/uploads/2017/05/IRU6.jpg)
![](https://www.chartmill.com/images/uploads/Undervalued_500_264px_webp_74997b3ff2.webp)
![](https://investorplace.com/wp-content/uploads/2022/06/biotechnologyepzm1600.png)
![](https://www.chartmill.com/images/uploads/thumbnail_article_navellier_3be8c6e05a.webp)
![](https://www.chartmill.com/images/uploads/Undervalued_500_264px_webp_74997b3ff2.webp)
![](https://www.chartmill.com/images/uploads/thumbnail_article_navellier_3be8c6e05a.webp)
![](https://www.investors.com/wp-content/uploads/2017/05/IRU77.jpg)
![](https://investorplace.com/wp-content/uploads/2021/11/shutterstock_1667119063.png)
![](https://investorplace.com/wp-content/uploads/2022/08/pharmaceutical1600.png)
![](https://www.chartmill.com/images/uploads/Affordable_Growth_500_264px_webp_add6a3aa59.webp)
![](https://www.investors.com/wp-content/uploads/2017/05/IRU33.jpg)
![](https://www.investors.com/wp-content/uploads/2017/05/IRU77.jpg)
![](https://www.chartmill.com/images/uploads/Affordable_Growth_500_264px_webp_add6a3aa59.webp)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_0.jpeg?width=1200&height=800&fit=crop)
Decoding 5 Analyst Evaluations For Alkermes
January 02, 2024
Via Benzinga
![](https://www.chartmill.com/images/uploads/thumbnail_article_navellier_3be8c6e05a.webp)
![](https://investorplace.com/wp-content/uploads/2022/10/droplet-test-tube-biotech-1600-3.jpg)
![](https://www.chartmill.com/images/uploads/Undervalued_500_264px_webp_74997b3ff2.webp)
![](https://www.chartmill.com/images/uploads/Affordable_Growth_500_264px_webp_add6a3aa59.webp)
![](https://www.chartmill.com/images/uploads/Undervalued_500_264px_webp_74997b3ff2.webp)
![](https://www.chartmill.com/images/uploads/thumbnail_article_navellier_3be8c6e05a.webp)
![](https://www.investors.com/wp-content/uploads/2019/07/UBERSTOCKTOBUY-Evergreen-070819-Shutter.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_1.jpeg?width=1200&height=800&fit=crop)
Where Alkermes Stands With Analysts
November 20, 2023
Via Benzinga
![](https://www.chartmill.com/images/uploads/Undervalued_500_264px_webp_74997b3ff2.webp)
![](https://www.chartmill.com/images/uploads/Affordable_Growth_500_264px_webp_add6a3aa59.webp)
![](https://investorplace.com/wp-content/uploads/2021/08/srne_doctor_oncology_1600.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.